Silari Marco
CERN, 1211 Geneva 23, Switzerland.
Radiat Prot Dosimetry. 2011 Jul;146(4):440-50. doi: 10.1093/rpd/ncr243. Epub 2011 Jun 14.
There are nearly 20,000 particle accelerators in operation worldwide, about half of them employed for biomedical uses. This paper focuses on some recent advances in the two main medical domains where accelerators find their use, radionuclide production and radiation therapy. The paper first discusses the use of high-energy electron and proton accelerators for the potential, future production of (99)Mo, which is presently provided by fission reactors. Next, it reviews the rationale for the use of protons and carbon ions in cancer therapy, discussing the requirements imposed on accelerator technology and looking at some recent developments.
全球范围内有近2万台粒子加速器在运行,其中约一半用于生物医学用途。本文重点关注加速器在两个主要医学领域的一些最新进展,即放射性核素生产和放射治疗。本文首先讨论了高能电子和质子加速器用于目前由裂变反应堆提供的(99)Mo的潜在未来生产。接下来,回顾了在癌症治疗中使用质子和碳离子的基本原理,讨论了对加速器技术的要求,并介绍了一些最新进展。